众生药业：公司正推进昂拉地韦片的商业化工作，昂拉地韦片目前线上线下均货源充足

Group 1 - The core issue raised by investors regarding the supply of Anglatide tablets, which sold 50 units and then went out of stock [2] - Zhongsheng Pharmaceutical (002317.SZ) confirmed on the investor interaction platform that it is advancing the commercialization of Anglatide tablets and that there is sufficient supply both online and offline [2]